Page last updated on July 16, 2024
ENZON PHARMACEUTICALS, INC. reported their cybersecurity risk management and governance process in a yearly 10-K filed on 2024-03-20 16:06:43 EDT.
Filings
10-K filed on 2024-03-20
ENZON PHARMACEUTICALS, INC. filed a 10-K at 2024-03-20 16:06:43 EDT
Accession Number: 0001410578-24-000245
Item 1C. Cybersecurity.
As we have positioned ourselves as a public company acquisition vehicle, and have limited operations, we do not have any significant operations that face cybersecurity threats. Although we do depend on the digital technologies of third parties, and any deliberate attacks on, or security breaches in, systems or infrastructure that we utilize, including those of third parties, could lead to corruption or misappropriation of our assets, information and sensitive or confidential data, we do not consider that we face significant cybersecurity risk and have not adopted any cybersecurity risk management program or formal processes for assessing cybersecurity risk. Our board of directors is generally responsible for the oversight of risks from cybersecurity threats, if there is any. In fiscal year 2023, we did not identify any cybersecurity threats that have materially affected or are reasonably likely to materially affect our business strategy, results of operations, or financial condition.
Company Information
Name | ENZON PHARMACEUTICALS, INC. |
CIK | 0000727510 |
SIC Description | Biological Products, (No Diagnostic Substances) |
Ticker | ENZN - OTC |
Website | |
Category | Non-accelerated filer Smaller reporting company |
Fiscal Year End | December 30 |